SMART Trademark

Trademark Overview


On Thursday, September 23, 2021, a trademark application was filed for SMART with the United States Patent and Trademark Office. The USPTO has given the SMART trademark a serial number of 97041678. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Friday, March 8, 2024. This trademark is owned by Entrada Therapeutics, Inc.. The SMART trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals for human use for the treatment of diseases, namely, pharmaceutical preparations for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes

Pharmaceutical research and development services
smart

General Information


Serial Number97041678
Word MarkSMART
Filing DateThursday, September 23, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateFriday, March 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals for human use for the treatment of diseases, namely, pharmaceutical preparations for prevention and treatment of inflammatory, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, oncological, and nephrological diseases and conditions mediated via intracellular transport processes
Goods and ServicesPharmaceutical research and development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 25, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEntrada Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Friday, March 8, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, September 6, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, February 11, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, February 11, 2023LETTER OF SUSPENSION E-MAILED
Saturday, February 11, 2023SUSPENSION LETTER WRITTEN
Thursday, December 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 2, 2022NON-FINAL ACTION E-MAILED
Thursday, June 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, May 25, 2022ASSIGNED TO EXAMINER
Monday, October 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 27, 2021NEW APPLICATION ENTERED